Aton Ra Partners Biogen Inc. Transaction History

Aton Ra Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $609,794 - $768,308	-3,147 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $52,173 - $67,050	233 Added 8.0%	3,147 $755,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $79,520 - $103,703	281 Added 10.67%	2,914 $825,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $34,706 - $55,571	-134 Reduced 4.84%	2,633 $912,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $672,242 - $787,571	2,767 New	2,767 $774,000

993

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.